Literature DB >> 11903314

Sex, genes and blood pressure.

J A Ellis1, Z Y Wong, M Stebbing, S B Harrap.   

Abstract

1. Throughout most of life, males have higher average blood pressures than females. This sexual dichotomy may be related to genetic factors including the X and Y sex chromosomes and genes that control sex steroids. Resultant physiological differences between men and women may also be relevant to the quantitative variation of blood pressure within the sexes. 2. The present overview collates our published and novel sex-related genetic data in relation to blood pressure from the Victorian Family Heart Study. These include a multipoint quantitative linkage analysis of the X chromosome and genetic association studies of single nucleotide polymorphisms (SNP) of the Y chromosome and genes encoding the androgen receptor (AR), oestrogen receptor alpha (ERalpha), 5alpha-reductase types I and II (SRD5A1 and SRD5A2) and aromatase (CYP19). 3. Systolic blood pressure (SBP) was linked (Z=3.3, genome-wide P < 0.05) to a region of the X chromosome that encompassed the AR gene and the Y chromosome was associated with diastolic blood pressure (DBP; P=0.03). In new analyses, we observed a possible association between a SNP in AR and DBP in 369 males (84.5 vs 82.1 mmHg for genotype A vs genotype B, respectively; P=0.06) and a significant association between haplotypes of the Y chromosome and AR SNP in males (P=0.01) with a difference of nearly 6 mmHg DBP between extreme groups. Associations were also observed for polymorphisms of SRD5A1 and ERalpha with DBP and SBP in males, respectively. 4. The findings indicate that genes related to sexual phenotypes may be relevant to the normal variation in blood pressure, even within the sexes. Further genetic and physiological analyses will be required to confirm these observations and to determine the mechanisms of action and the nature of any interactions.

Entities:  

Mesh:

Year:  2001        PMID: 11903314     DOI: 10.1046/j.1440-1681.2001.03579.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  5 in total

1.  A genetic polymorphism in the CYP19A1 gene and the risk of hypertension among midlife women.

Authors:  Ayelet Ziv-Gal; Lisa Gallicchio; Susan R Miller; Howard A Zacur; Jodi A Flaws
Journal:  Maturitas       Date:  2011-11-21       Impact factor: 4.342

Review 2.  A comprehensive view of sex-specific issues related to cardiovascular disease.

Authors:  Louise Pilote; Kaberi Dasgupta; Veena Guru; Karin H Humphries; Jennifer McGrath; Colleen Norris; Doreen Rabi; Johanne Tremblay; Arsham Alamian; Tracie Barnett; Jafna Cox; William Amin Ghali; Sherry Grace; Pavel Hamet; Teresa Ho; Susan Kirkland; Marie Lambert; Danielle Libersan; Jennifer O'Loughlin; Gilles Paradis; Milan Petrovich; Vicky Tagalakis
Journal:  CMAJ       Date:  2007-03-13       Impact factor: 8.262

3.  Measurement of absolute copy number variation reveals association with essential hypertension.

Authors:  Francine Z Marques; Priscilla R Prestes; Leonardo B Pinheiro; Katrina Scurrah; Kerry R Emslie; Maciej Tomaszewski; Stephen B Harrap; Fadi J Charchar
Journal:  BMC Med Genomics       Date:  2014-07-15       Impact factor: 3.063

4.  The possible role of chromosome X variability in hypertensive familiarity.

Authors:  M Ciccarelli; R Finelli; N Rivera; G Santulli; R Izzo; N De Luca; F Rozza; M Ceccarelli; S Pagnotta; F Uliano; R Tremigliozzi; G Condorelli; V Trimarco; G Iaccarino
Journal:  J Hum Hypertens       Date:  2016-02-25       Impact factor: 3.012

5.  Gene expression profiling of lymphoblasts from autistic and nonaffected sib pairs: altered pathways in neuronal development and steroid biosynthesis.

Authors:  Valerie W Hu; AnhThu Nguyen; Kyung Soon Kim; Mara E Steinberg; Tewarit Sarachana; Michele A Scully; Steven J Soldin; Truong Luu; Norman H Lee
Journal:  PLoS One       Date:  2009-06-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.